I/S Tandklinikken Omhu

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  0.5% 0.5% 0.5% 0.5% 0.5%  
Bankruptcy risk  0.0% 12.6% 13.3% 2.0% 1.8%  
Credit score (0-100)  0 17 16 68 71  
Credit rating  N/A BB BB A A  
Credit limit (kDKK)  0.0 0.0 0.0 0.8 3.1  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  0.0 7,459 8,368 8,367 10,785  
EBITDA  0.0 3,087 3,792 3,909 5,191  
EBIT  0.0 3,087 3,792 3,826 4,651  
Pre-tax profit (PTP)  0.0 3,081.5 3,779.2 3,245.6 3,854.5  
Net earnings  0.0 3,081.5 3,779.2 3,245.6 3,854.5  
Pre-tax profit without non-rec. items  0.0 3,081 3,779 3,246 3,854  

 
See the entire income statement

Balance sheet (kDKK) 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  0.0 0.0 0.0 15,457 15,690  
Shareholders equity total  0.0 666 1,509 2,030 3,161  
Interest-bearing liabilities  0.0 0.0 0.0 9,129 8,234  
Balance sheet total (assets)  0.0 1,242 2,063 15,751 15,992  

Net Debt  0.0 -985 -1,745 9,090 8,212  
 
See the entire balance sheet

Volume 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 7,459 8,368 8,367 10,785  
Gross profit growth  0.0% 0.0% 12.2% -0.0% 28.9%  
Employees  0 3 3 7 10  
Employee growth %  0.0% 0.0% 0.0% 133.3% 42.9%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 1,242 2,063 15,751 15,992  
Balance sheet change%  0.0% 0.0% 66.1% 663.6% 1.5%  
Added value  0.0 3,086.6 3,792.1 3,825.7 5,190.5  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 15,374 -307  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 1.0 2.0 3.0 4.0  

Profitability 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 41.4% 45.3% 45.7% 43.1%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 248.6% 229.7% 43.5% 29.3%  
ROI %  0.0% 463.8% 349.0% 61.2% 41.3%  
ROE %  0.0% 462.8% 347.6% 183.4% 148.5%  

Solidity 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  0.0% 53.6% 73.9% 12.9% 19.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% -31.9% -46.0% 232.5% 158.2%  
Gearing %  0.0% 0.0% 0.0% 449.6% 260.5%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 13.8% 9.2%  

Liquidity 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  0.0 2.1 3.8 0.0 0.1  
Current Ratio  0.0 2.2 3.7 0.1 0.1  
Cash and cash equivalent  0.0 984.9 1,745.4 38.5 22.0  

Capital use efficiency 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 665.9 1,508.7 -5,459.8 -5,449.7  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 1,029 1,264 547 519  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 1,029 1,264 558 519  
EBIT / employee  0 1,029 1,264 547 465  
Net earnings / employee  0 1,027 1,260 464 385